Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (58)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Monnier, N.
Right arrow Articles by Lunardi, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Monnier, N.
Right arrow Articles by Lunardi, J.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Human Molecular Genetics, 2001, Vol. 10, No. 22 2581-2592
© 2001 Oxford University Press

Familial and sporadic forms of central core disease are associated with mutations in the C-terminal domain of the skeletal muscle ryanodine receptor

Nicole Monnier1, Norma Beatriz Romero2, Joëlle Lerale1, Pierre Landrieu3, Yves Nivoche4, Michel Fardeau2 and Joël Lunardi1,5,+

1Laboratoire de Biochimie de l’ADN, CHU Grenoble, Grenoble, France, 2INSERM U523 and Institut de Myologie, Hôpital de la Salpétrière, Paris, France, 3Département de Pédiatrie, CHU Bicêtre, Le Kremlin-Bicêtre, France, 4Département d’Anesthésie, Hôpital Robert Debré, Paris, France and 5Laboratoire BECP/DBMS, EA 2943 UJF—CEA, Grenoble, France

Central core disease (CCD) is an autosomal dominant congenital myopathy. Diagnosis is based on the presence of cores in skeletal muscles. CCD has been linked to the gene encoding the ryanodine receptor (RYR1) and is considered to be an allelic disease of malignant hyperthermia susceptibility. However, the report of a recessive form of transmission together with a variable clinical presentation has raised the question of the genetic heterogeneity of the disease. Analyzing a panel of 34 families exclusively recruited on the basis of both clinically and morphologically expressed CCD, 12 different mutations of the C-terminal domain of RYR1 have been identified in 16 unrelated families. Morphological analysis of the patients’ muscles showed different aspects of cores, all of them associated with mutations in the C-terminal region of RYR1. Furthermore, we characterized the presence of neomutations in the RyR1 gene in four families. This indicates that neomutations into the RyR1 gene are not a rare event and must be taken into account for genetic studies of families that present with congenital myopathies type ‘central core disease’. Three mutations led to the deletion in frame of amino acids. This is the first report of amino acid deletions in RYR1 associated with CCD. According to a four-transmembrane domain model, the mutations concentrated mostly in the myoplasmic and luminal loops linking, respectively, transmembrane domains T1 and T2 or T3 and T4 of RYR1.

+ To whom correspondence should be addressed at: Laboratoire Biochimie de l’ADN, EA 2943 UJF, CHU Grenoble BP 217, 38043 Grenoble Cedex, France. Tel: +33 4 76 76 55 73; Fax: +33 4 76 76 58 37; Email: jlunardi@chu-grenoble.fr


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
L. Xu, Y. Wang, N. Yamaguchi, D. A. Pasek, and G. Meissner
Single Channel Properties of Heterotetrameric Mutant RyR1 Ion Channels Linked to Core Myopathies
J. Biol. Chem., March 7, 2008; 283(10): 6321 - 6329.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
I. Sato, S. Wu, M. C. A. Ibarra, Y. K. Hayashi, H. Fujita, M. Tojo, S. J. Oh, I. Nonaka, S. Noguchi, and I. Nishino
Congenital neuromuscular disease with uniform type 1 fiber and RYR1 mutation
Neurology, January 8, 2008; 70(2): 114 - 122.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
H. Zhou, H. Jungbluth, C. A. Sewry, L. Feng, E. Bertini, K. Bushby, V. Straub, H. Roper, M. R. Rose, M. Brockington, et al.
Molecular mechanisms and phenotypic variation in RYR1-related congenital myopathies
Brain, August 1, 2007; 130(8): 2024 - 2036.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
D. Fischer, M. Herasse, A. Ferreiro, H. M. Barragan-Campos, J. Chiras, L. Viollet, S. Maugenre, J. -P. Leroy, N. Monnier, J. Lunardi, et al.
Muscle imaging in dominant core myopathies linked or unlinked to the ryanodine receptor 1 gene
Neurology, December 26, 2006; 67(12): 2217 - 2220.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
H. Zhou, N. Yamaguchi, L. Xu, Y. Wang, C. Sewry, H. Jungbluth, F. Zorzato, E. Bertini, F. Muntoni, G. Meissner, et al.
Characterization of recessive RYR1 mutations in core myopathies
Hum. Mol. Genet., September 15, 2006; 15(18): 2791 - 2803.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
S. Wu, M C. A. Ibarra, M. C. V. Malicdan, K. Murayama, Y. Ichihara, H. Kikuchi, I. Nonaka, S. Noguchi, Y. K. Hayashi, and I. Nishino
Central core disease is due to RYR1 mutations in more than 90% of patients
Brain, June 1, 2006; 129(6): 1470 - 1480.
[Abstract] [Full Text] [PDF]


Home page
J. Med. Genet.Home page
S Shepherd, F Ellis, J Halsall, P Hopkins, and R Robinson
RYR1 mutations in UK central core disease patients: more than just the C-terminal transmembrane region of the RYR1 gene
J. Med. Genet., March 1, 2004; 41(3): e33 - 33.
[Full Text] [PDF]


Home page
Arch NeurolHome page
K. D. Mathews and S. A. Moore
Multiminicore Myopathy, Central Core Disease, Malignant Hyperthermia Susceptibility, and RYR1 Mutations: One Disease With Many Faces?
Arch Neurol, January 1, 2004; 61(1): 27 - 29.
[Full Text] [PDF]


Home page
Arch. Dis. Child.Home page
R M Quinlivan, C R Muller, M Davis, N G Laing, G A Evans, J Dwyer, J Dove, A P Roberts, and C A Sewry
Central core disease: clinical, pathological, and genetic features
Arch. Dis. Child., December 1, 2003; 88(12): 1051 - 1055.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
N. B. Romero, N. Monnier, L. Viollet, A. Cortey, M. Chevallay, J. P. Leroy, J. Lunardi, and M. Fardeau
Dominant and recessive central core disease associated with RYR1 mutations and fetal akinesia
Brain, November 1, 2003; 126(11): 2341 - 2349.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
T. Yang, T. A. Ta, I. N. Pessah, and P. D. Allen
Functional Defects in Six Ryanodine Receptor Isoform-1 (RyR1) Mutations Associated with Malignant Hyperthermia and Their Impact on Skeletal Excitation-Contraction Coupling
J. Biol. Chem., July 3, 2003; 278(28): 25722 - 25730.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
N. Monnier, A. Ferreiro, I. Marty, A. Labarre-Vila, P. Mezin, and J. Lunardi
A homozygous splicing mutation causing a depletion of skeletal muscle RYR1 is associated with multi-minicore disease congenital myopathy with ophthalmoplegia
Hum. Mol. Genet., May 15, 2003; 12(10): 1171 - 1178.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
F. Zorzato, N. Yamaguchi, L. Xu, G. Meissner, C. R. Muller, P. Pouliquin, F. Muntoni, C. Sewry, T. Girard, and S. Treves
Clinical and functional effects of a deletion in a COOH-terminal lumenal loop of the skeletal muscle ryanodine receptor
Hum. Mol. Genet., February 15, 2003; 12(4): 379 - 388.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.